Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-006271-37Phase 2Completed
Phase 2, single-arm trial of Pramipexole or Ropinirole in tinnitus and presbycusis, sponsored by University of Debrecen Department of Otolaryngology, Head and Neck Surgery. Primary endpoints: Hearing outcome at 4 weeks and Hearing outcome at 12 weeks. Started Dec 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-006271-37.